The following article by Andrew Siddons was posed on the Roll Call website May 14, 2018:
Trump calls overseas costs unfair compared to U.S.
President Donald Trump took aim at “global freeloading” in his Friday speech on drug prices, putting an “America First” angle on a complicated policy issue. Although Trump’s rhetoric in the speech was fairly tough on the pharmaceutical industry, this issue was one area where Trump was borrowing a page from the Big Pharma playbook.
For all the resonance this part of the drug pricing debate might have with Trump and his political supporters, the administration’s accompanying policy blueprint had few details on how to address what other countries pay for prescription drugs. Questions remain over whether higher prices overseas would translate into lower prices in the United States. Continue reading “Questions Surround ‘America First’ Plan on Overseas Drug Prices”